Non-melanoma skin cancer treated with high-dose-rate brachytherapy: a review of literature.

Delishaj, D; Rembielak, Agata; Manfredi, B; Ursino, S; Pasqualetti, F; Laliscia, C; Orlandi, F; Morganti, R; Fabrini, Maria G; Paiar, F

dc.contributor.author	Delishaj, D
dc.contributor.author	Rembielak, Agata
dc.contributor.author	Manfredi, B
dc.contributor.author	Ursino, S
dc.contributor.author	Pasqualetti, F
dc.contributor.author	Laliscia, C
dc.contributor.author	Orlandi, F
dc.contributor.author	Morganti, R
dc.contributor.author	Fabrini, Maria G
dc.contributor.author	Paiar, F
dc.date.accessioned	2017-03-04T18:58:56Z
dc.date.available	2017-03-04T18:58:56Z
dc.date.issued	2016-12
dc.identifier.citation	Non-melanoma skin cancer treated with high-dose-rate brachytherapy: a review of literature. 2016, 8(6):533-540 J Contemp Brachytherapy	en
dc.identifier.issn	1689-832X
dc.identifier.pmid	28115960
dc.identifier.doi	10.5114/jcb.2016.64112
dc.identifier.uri	http://hdl.handle.net/10541/620173
dc.description.abstract	The incidence of non-melanoma skin cancer (NMSC) has been increasing over the past 30 years. There are different treatment options and surgical excision is the most frequent treatment due to its low rates of recurrence. Radiotherapy is an effective alternative of surgery, and brachytherapy (BT) might be a better therapeutic option due to high radiation dose concentration to the tumor with rapid dose fall-off resulting in normal tissues sparing. The aim of this review was to evaluate the local control, toxicity, and cosmetic outcomes in NMSC treated with high-dose-rate BT (HDR-BT).
dc.language.iso	en	en
dc.rights	Archived with thanks to Journal of contemporary brachytherapy	en
dc.title	Non-melanoma skin cancer treated with high-dose-rate brachytherapy: a review of literature.	en
dc.type	Article	en
dc.contributor.department	Department of Translational Medicine, Division of Radiation Oncology - University of Pisa, Pisa, Italy	en
dc.identifier.journal	Journal of Contemporary Brachytherapy	en
refterms.dateFOA	2018-12-17T14:48:44Z
html.description.abstract	The incidence of non-melanoma skin cancer (NMSC) has been increasing over the past 30 years. There are different treatment options and surgical excision is the most frequent treatment due to its low rates of recurrence. Radiotherapy is an effective alternative of surgery, and brachytherapy (BT) might be a better therapeutic option due to high radiation dose concentration to the tumor with rapid dose fall-off resulting in normal tissues sparing. The aim of this review was to evaluate the local control, toxicity, and cosmetic outcomes in NMSC treated with high-dose-rate BT (HDR-BT).